Stock Details
DGX is Quest Diagnostics Incorporated's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 142.85$. Average daily volumn in 3 months 1.15M. Market cap 14.95B

Stock symbol : DGX. Exchange : NYSE. Currency : USD
Lastest price : 134.32$. Total volume : 1.45M. Market state POST
Click reload if you want to check the lastest price on market!!!

Quest Diagnostics Incorporated (DGX)
Last Price

Previous Close135.91
Day Range134.26-137.23
Bid132.74 x 1k
Ask136.45 x 800
Average Volume1.15M
Market Cap14.95B
52 Week Range120.40-158.34
Trailing P/E16.48
Foward P/E14.58
Dividend (Yield %)2.14%
Ex-Dividend Date2023-04-06

Financial Details

According to Quest Diagnostics Incorporated's financial reports the company's revenue in 2022 were 9.88B an increase(-10%) over the years 2021 revenue that were of 10.79B. In 2022 the company's total earnings were 946M while total earnings in 2021 were 2B(-52.7%).

Loading ...



Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brand... s to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Market Cap:
Total Assets:
Total Cash:

News about "Quest Diagnostics Incorporated"

Quest Diagnostics Incorporated (DGX) Shares Up Despite Recent Market Volatility

Source from : newsheater - 20 hours ago

Quest Diagnostics Incorporated (NYSE: DGX)โ€™s stock price has increased by 2.26 compared to its previous closing price of 132.91. Nevertheless, the company has seen a 1.50% surge in its stock price ...See details»

Quest Diagnostics Remains A Solid Long-Term Company

Source from : Seeking Alpha - 2 days ago

While Quest Diagnostics Incorporated's (NYSE:DGX) profitability margins have been affected in the short term, the company remains financially stable with solid cash flow from operations.See details»

Quest Diagnostics Inc

Source from : Newsweek - 12 days ago

Quest Diagnostics Incorporated is a Fortune 500 American company providing clinical laboratory services with headquarters in Secaucus, New Jersey. Founded in 1967 as Metropolitan Pathology ...See details»

Quest Diagnostics (DGX) Acquires Northern Light Laboratory

Source from : Yahoo Finance - 21 hours ago

Quest Diagnostics, Inc. DGX announced the closure of its previously announced acquisition of select assets of Northern Light Laboratory -- a large integrated healthcare system in Maine. Financial ...See details»


Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors

Source from : MarketWatch - 7 days ago

Shares of Quest Diagnostics Inc. slumped 0.78% to $132.85 Wednesday, on what proved to be an all-around grim trading session for the stock market, with ...See details»

Quest Diagnostics Incorporated

Source from : Fortune - 3 years ago

ยฉ 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»


Roche teams up with Lilly to validate Alzheimer's blood test

Source from : Reuters - 1 days ago

Roche and Eli Lilly and Co are joining forces to develop a blood test for Alzheimer's disease, and plan to kick off a two-year clinical trial involving hundreds of volunteers with the aim of winning U ...See details»

Reasons to Add Quest Diagnostics (DGX) Stock to Your Portfolio

Source from : Nasdaq - 22 days ago

Quest Diagnostics Incorporated DGX has been gaining on the back of its improvements in its base volumes. The optimism led by solid fourth-quarter 2022 performance and its tactical approaches to ...See details»

Quest Diagnostics to Discuss Strategic Priorities to Drive Growth and Create Shareholder Value at 2023 Investor Day

Source from : Stockhouse - 6 days ago

members of the executive leadership team of Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, will discuss the company's priorities to grow ...See details»

New Suit - Consumer Class Action

Source from : Law - 1 month ago

Counsel have not yet appeared for the defendants. The case is 8:23-cv-00285, Ager v. Quest Diagnostics Incorporated et al.See details»

Dividend History

Source from : Seeking Alpha - 2 days ago

To ensure this doesnโ€™t happen in the future, please enable Javascript and cookies in your browser. Is this happening to you frequently? Please report it on our ...See details»

Quest Diagnostics Incorporated Common Stock (DGX)

Source from : Nasdaq - 10 years ago

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stockโ€™s expected performance in a given time period based on ...See details»

Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Quest Diagnostics (DGX) and Globus Medical (GMED)

Source from : Business Insider - 5 days ago

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioMarin Pharmaceutical (BMRN โ€“ Research ...See details»

Quest Diagnostics Completes Acquisition of Northern Light Laboratory in Maine

Source from : Stockhouse - 2 days ago

SECAUCUS, N.J., March 20, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced it has completed its previously ...See details»